PL343494A1 - Treatment of generalized anxiety disorder with paroxetine - Google Patents

Treatment of generalized anxiety disorder with paroxetine

Info

Publication number
PL343494A1
PL343494A1 PL99343494A PL34349499A PL343494A1 PL 343494 A1 PL343494 A1 PL 343494A1 PL 99343494 A PL99343494 A PL 99343494A PL 34349499 A PL34349499 A PL 34349499A PL 343494 A1 PL343494 A1 PL 343494A1
Authority
PL
Poland
Prior art keywords
paroxetine
treatment
anxiety disorder
generalized anxiety
generalized
Prior art date
Application number
PL99343494A
Other languages
English (en)
Inventor
Rocco Zaninelli
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PL343494A1 publication Critical patent/PL343494A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL99343494A 1998-04-22 1999-04-22 Treatment of generalized anxiety disorder with paroxetine PL343494A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9808479.1A GB9808479D0 (en) 1998-04-22 1998-04-22 Method of treatment
PCT/US1999/008786 WO1999053919A1 (en) 1998-04-22 1999-04-22 Treatment of generalized anxiety disorder with paroxetine

Publications (1)

Publication Number Publication Date
PL343494A1 true PL343494A1 (en) 2001-08-27

Family

ID=10830715

Family Applications (1)

Application Number Title Priority Date Filing Date
PL99343494A PL343494A1 (en) 1998-04-22 1999-04-22 Treatment of generalized anxiety disorder with paroxetine

Country Status (20)

Country Link
EP (1) EP1073437A4 (hu)
JP (1) JP2002512189A (hu)
KR (1) KR20010034817A (hu)
CN (1) CN1298301A (hu)
AP (1) AP2000001959A0 (hu)
AU (1) AU3864899A (hu)
BG (1) BG104939A (hu)
BR (1) BR9909791A (hu)
CA (1) CA2328896A1 (hu)
CZ (1) CZ20003885A3 (hu)
EA (1) EA200001088A1 (hu)
GB (1) GB9808479D0 (hu)
HU (1) HUP0101350A3 (hu)
ID (1) ID27546A (hu)
IL (1) IL139167A0 (hu)
NO (1) NO20005286L (hu)
PL (1) PL343494A1 (hu)
SK (1) SK15672000A3 (hu)
TR (1) TR200003082T2 (hu)
WO (1) WO1999053919A1 (hu)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550C2 (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
EA200001088A1 (ru) 2001-04-23
HUP0101350A2 (hu) 2002-05-29
AP2000001959A0 (en) 2000-12-31
NO20005286L (no) 2000-12-20
CA2328896A1 (en) 1999-10-28
HUP0101350A3 (en) 2002-06-28
BG104939A (bg) 2001-09-28
IL139167A0 (en) 2001-11-25
WO1999053919A1 (en) 1999-10-28
GB9808479D0 (en) 1998-06-17
JP2002512189A (ja) 2002-04-23
EP1073437A1 (en) 2001-02-07
NO20005286D0 (no) 2000-10-20
CZ20003885A3 (cs) 2001-09-12
EP1073437A4 (en) 2003-04-16
ID27546A (id) 2001-04-12
CN1298301A (zh) 2001-06-06
KR20010034817A (ko) 2001-04-25
TR200003082T2 (tr) 2001-01-22
SK15672000A3 (sk) 2001-04-09
BR9909791A (pt) 2000-12-26
AU3864899A (en) 1999-11-08

Similar Documents

Publication Publication Date Title
EP1200086A4 (en) THERAPEUTIC OR PROPHYLACTIC METHODS OF PAIN AND ANXIETY
GB2337763B (en) Methods of treating preform elements
HK1047693A1 (zh) 治療全身性焦慮障礙的環苯扎林及其組合物
IL134718A0 (en) Treatment of conduct disorder
EP0996433A4 (en) METHODS OF TREATING LACTOSYLCERAMIDE-RELATED CONDITIONS
EP1117395A4 (en) COMPOUNDS FOR THE TREATMENT OF ESTROGEN-DEPENDENT DISEASES AND THEIR PRODUCTION AND USE METHODS
EP1071339A4 (en) TREATMENT OF ANIMALS BY DIHYDROXYCHINOLINE COMPOUNDS
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
HUP0102886A2 (en) Treatment of anxiety disorders
IL139167A0 (en) Treatment of generalized anxiety disorder with paroxetine
IL126681A0 (en) Treatment of trauma-related conditions
IL149533A0 (en) Treatment of sle with dehydropiandrosterone
GB9812941D0 (en) Method of treatment
HU9904062D0 (en) Fixing rail with holes and process for making of fixing rail
GB2365419B (en) Treatment of effluents
GB9917590D0 (en) Treatment of fibres
GB9819800D0 (en) Treatment of fibres
GB9818295D0 (en) Treatment of alopecia
GB9822681D0 (en) Method of treatment
SI1117403T1 (en) Mglur5 antagonists for the treatment of pain and anxiety
GB9824208D0 (en) Methods of treatment
GB9822458D0 (en) Methods of treatment
GB9800707D0 (en) Methods of treatment
DK82798A (da) Treatment of GABA-uptake related disorders
UA33583A (uk) Спосіб терапії простої шизофренії

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)